|
[1]
|
Escapa, I.F., Chen, T., Huang, Y., et al. (2018) New Insights into Human Nostril Microbiome from the Expanded Hu-man Oral Microbiome Database (eHOMD): A Resource for the Microbiome of the Human Aerodigestive Tract. Msys-tems, 3, e00187-18. [Google Scholar] [CrossRef]
|
|
[2]
|
Solbiati, J. and Frias-Lopez, J. (2018) Meta-transcriptome of the Oral Microbiome in Health and Disease. Journal of Dental Research, 97, 492-500. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Graves, D.T., Correa, J.D. and Silva, T.A. (2019) The Oral Mi-crobiota Is Modified by Systemic Diseases. Journal of Dental Research, 98, 148-156. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Hajishengallis, G. (2015) Periodontitis: From Microbial Immune Subversion to Systemic Inflammation. Nature Reviews Immunology, 15, 30-44. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Gevers, D., Kugathasan, S., Denson, L.A., et al. (2014) The Treatment-Naive Microbiome in New-Onset Crohn’s Disease. Cell Host & Microbe, 15, 382-392. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Karpinski, T.M. (2019) Role of Oral Microbiota in Cancer De-velopment. Microorganisms, 7, 20. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kawasaki, M., Ikeda, Y., Ikeda, E., et al. (2021) Oral Infec-tious Bacteria in Dental Plaque and Saliva as Risk Factors in Patients with Esophageal Cancer. Cancer, 127, 512-519. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Narikiyo, M., Tanabe, C., Yamada, Y., et al. (2004) Frequent and Prefer-ential Infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in Esophageal Cancers. Can-cer Science, 95, 569-574. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Peters, B.A., Wu, J., Pei, Z., et al. (2017) Oral Microbi-ome Composition Reflects Prospective Risk for Esophageal Cancers. Cancer Research, 77, 6777-6787. [Google Scholar] [CrossRef]
|
|
[10]
|
Chen, M.-F., Lu, M.-S., Hsieh, C.-C., et al. (2021) Por-phyromonas gingivalis Promotes Tumor Progression in Esophageal Squamous Cell Carcinoma. Cellular Oncology, 44, 373-384. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Corning, B., Copland, A.P. and Frye, J.W. (2018) The Esophageal Microbiome in Health and Disease. Current Gastroenterology Reports, 20, 39-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Libby, P. (2017) Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond. Journal of the American College of Cardiology, 70, 2278-2289. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Carmi, Y., Dotan, S., Rider, P., et al. (2013) The Role of IL-1 Beta in the Early Tumor Cell-Induced Angiogenic Response. Journal of Immunology, 190, 3500-3509. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Jin, L., Yuan, R.Q., Fuchs, A., et al. (1997) Expression of Inter-leukin-1beta in Human Breast Carcinoma. Cancer, 80, 421-434. [Google Scholar] [CrossRef]
|
|
[15]
|
Voronov, E., Shouval, D.S., Krelin, Y., et al. (2003) IL-1 Is Required for Tumor Invasiveness and Angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 100, 2645-2650. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wang, F.M., Liu, H.Q., Liu, S.R., et al. (2005) SHP-2 Promoting Migration and Metastasis of MCF-7 with Loss of E-cadherin, Dephosphorylation of FAK and Secretion of MMP-9 In-duced by IL-1 Beta in Vivo and in Vitro. Breast Cancer Research and Treatment, 89, 5-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Li, S.J., Qin, X.B., Chai, S., et al. (2016) Modulation of E-cadherin Expression Promotes Migration Ability of Esophageal Cancer Cells. Scientific Reports, 6, Article No. 21713. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wong, S.H.M., Fang, C.M., Chuah, L.-H., et al. (2018) E-cadherin: Its Dysregulation in Carcinogenesis and Clinical Implications. Critical Reviews in Oncology Hematology, 121, 11-22. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Gabay, C. (2006) Interleukin-6 and Chronic Inflammation. Arthritis Research & Therapy, 8, S3. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ishimi, Y., Miyaura, C., Jin, C.H., et al. (1990) IL-6 Is Produced by Osteo-blasts and Induces Bone Resorption. Journal of Immunology (Baltimore, Md.: 1950), 145, 3297-3303. [Google Scholar] [CrossRef]
|
|
[21]
|
Mathy-Hartert, M., Hogge, L., Sanchez, C., et al. (2008) Inter-leukin-1 beta and Interleukin-6 Disturb the Antioxidant Enzyme System in Bovine Chondrocytes: A Possible Explanation for Oxidative Stress Generation. Osteoarthritis and Cartilage, 16, 756-763. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Murata, M., Thanan, R., Ma, N., et al. (2012) Role of Nitrative and Oxidative DNA Damage in Inflammation-Related Carcinogenesis. Journal of Biomedicine and Biotechnology, 2012, Ar-ticle ID: 623019. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Kossakowska, A.E., Edwards, D.R., Prusinkiewicz, C., Zhang, M.C., et al. (1999) Interleukin-6 Regulation of Matrix Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metallo-proteinase (TIMP-1) Expression in Malignant Non-Hodgkin’s Lymphomas. Blood, 94, 2080-2089. [Google Scholar] [CrossRef]
|
|
[24]
|
Natali, P., Nicotra, M.R., Cavaliere, R., et al. (1990) Differential Expression of Intercellular Adhesion Molecule 1 in Primary and Metastatic Melanoma Lesions. Cancer Research, 50, 1271-1278.
|
|
[25]
|
Janney, A., Powrie, F. and Mann, E.H. (2020) Host-Microbiota Maladaptation in Colorectal Cancer. Nature, 585, 509-517. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yang, Y., Cai, Q., Shu, X.O., et al. (2017) Abstract 4931: Prospective Study of Oral Microbiome and Colorectal Cancer Risk in Low-Income and African American Populations. Cancer Research, 77, Article No. 4931. [Google Scholar] [CrossRef]
|
|
[27]
|
Flemer, B., Warren, R.D., Barrett, M.P., et al. (2018) The Oral Microbiota in Colorectal Cancer Is Distinctive and Predictive. Gut, 67, 1454-1463. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zhang, S., Kong, C., Yang, Y., et al. (2020) Human Oral Micro-biome Dysbiosis as a Novel Non-Invasive Biomarker in Detection of Colorectal Cancer. Theranostics, 10, 11595-11606. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Kostic, A.D., Gevers, D., Pedamallu, C.S., et al. (2012) Genomic Analysis Identifies Association of Fusobacterium with Colorectal Carcinoma. Genome Research, 22, 292-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Komiya, Y., Shimomura, Y., Higurashi, T., et al. (2019) Patients with Colorectal Cancer Have Identical Strains of Fusobacterium nucleatum in Their Colorectal Cancer and Oral Cavity. Gut, 68, 1335-1337. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Coppenhagen-Glazer, S., Sol, A., Abed, J., et al. (2015) Fap2 of Fusobacterium nucleatum Is a Galactose-Inhibitable Adhesin Involved in Coaggregation, Cell Adhesion, and Preterm Birth. Infection and Immunity, 83, 1104-1113. [Google Scholar] [CrossRef]
|
|
[32]
|
Gur, C., Ibrahim, Y., Isaacson, B., et al. (2015) Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack. Immunity, 42, 344-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Kostic, A.D., Chun, E.Y., Robertson, L., et al. (2013) Fuso-bacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host & Microbe, 14, 207-215. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Abed, J., Emgard, J.E.M., Zamir, G., et al. (2016) Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc. Cell Host & Microbe, 20, 215-225. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Casasanta, M.A., Yoo, C.C., Udayasuryan, B., et al. (2020) Fusobacterium nucleatum Host-Cell Binding and Invasion Induces IL-8 and CXCL1 Secretion That Drives Colorectal Cancer Cell Migration. Science Signaling, 13, eaba9157. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Rubinstein, M.R., Wang, X.W., Liu, W.D., et al. (2013) Fusobacte-rium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/beta-Catenin Signaling via Its FadA Adhesin. Cell Host & Microbe, 14, 195-206. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Rubinstein, M.R., Baik, J.E., Lagana, S.M., et al. (2019) Fuso-bacterium nucleatum Promotes Colorectal Cancer by Inducing Wnt/beta-Catenin Modulator Annexin A1. EMBO Reports, 20, e47638. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Yang, Y.Z., Weng, W.H., Peng, J.J., et al. (2017) Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-kappaB, and Up-Regulating Expression of MicroRNA-21. Gastroenterology, 152, 851-866. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Fan, X., Alekseyenko, A.V., Wu, J., et al. (2016) Human Oral Microbiome and Prospective Risk for Pancreatic Cancer: A Population Based, Nested Case Control Study. Cancer Re-search, 76, Article No. 4350. [Google Scholar] [CrossRef]
|
|
[40]
|
Pan, C., Xu, X., Tan, L., et al. (2014) The Effects of Por-phyromonas gingivalis on the Cell Cycle Progression of Human Gingival Epithelial Cells. Oral Diseases, 20, 100-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Stasiewicz, M. and Karpinski, T.M. (2022) The Oral Microbiota and Its Role in Carcinogenesis. Seminars in Cancer Biology, 86, 633-642. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Moon, J.H., Lee, J.H. and Lee, J.Y. (2015) Subgingival Mi-crobiome in Smokers and Non-Smokers in Korean Chronic Periodontitis Patients. Molecular Oral Microbiology, 30, 227-241. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Tijeras-Raballand, A., Hilmi, M., Astorgues-Xerri, L., et al. (2021) Microbiome and Pancreatic Ductal Adenocarcinoma. Clinics and Research in Hepatology and Gastroenterology, 45, Article ID: 101589. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Friedlander, S.Y.G., Chu, G.C., Snyder, E.L., et al. (2009) Con-text-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras. Cancer Cell, 16, 379-389. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Aguirre, A.J., Hruban, R.H., Raphael, B.J., et al. (2017) Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32, 185-203.e13. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Ren, Z.G., Jiang, J.W., Xie, H.Y., et al. (2017) Gut Microbial Pro-file Analysis by MiSeq Sequencing of Pancreatic Carcinoma Patients in China. Oncotarget, 8, 95176-95191. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Huang, H., Daniluk, J., Liu, Y., et al. (2014) Oncogenic K-Ras Requires Activation for Enhanced Activity. Oncogene, 33, 532-535. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Mao, S., Park, Y., Hasegawa, Y., et al. (2007) Intrinsic Apoptotic Pathways of Gingival Epithelial Cells Modulated by Porphyromonas gingivalis. Cellular Microbiology, 9, 1997-2007. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Ikezawa, K., Hikita, H., Shigekawa, M., et al. (2017) In-creased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis. Cellular and Molecular Gastroenterology and Hepatology, 4, 185-200.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Lofgren, J.L., Whary, M.T., Ge, Z.M., et al. (2011) Lack of Commensal Flora in Helicobacter pylori-Infected INS-GAS Mice Reduces Gastritis and Delays Intraepithelial Neoplasia. Gastroenterology, 140, 210-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Wu, J., Xu, S., Xiang, C.J., et al. (2018) Tongue Coating Micro-biota Community and Risk Effect on Gastric Cancer. Journal of Cancer, 9, 4039-4048. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Zhao, Y.N., Zhang, J.L., Cheng, A.S.L., et al. (2020) Gastric Cancer: Ge-nome Damaged by Bugs. Oncogene, 39, 3427-3442. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Enroth, H., Kraaz, W., Engstrand, L., et al. (2000) Helicobacter pylori Strain Types and Risk of Gastric Cancer: A Case-Control Study. Cancer Epidemiology Biomarkers & Prevention, 9, 981-985.
|
|
[54]
|
Higashi, H., Nakaya, A., Tsutsumi, R., et al. (2004) Helicobacter pylori CagA Induces Ras-Independent Morphogenetic Response through SHP-2 Recruitment and Activation. Journal of Biological Chemistry, 279, 17205-17216. [Google Scholar] [CrossRef]
|
|
[55]
|
Tsutsumi, R., Takahashi, A., Azuma, T., et al. (2006) Focal Adhe-sion Kinase Is a Substrate and Downstream Effector of SHP-2 Complexed with Helicobacter pylori CagA. Molecular and Cellular Biology, 26, 261-276. [Google Scholar] [CrossRef]
|
|
[56]
|
Suzuki, M., Mimuro, H., Kiga, K., et al. (2009) Helicobacter pylori CagA Phosphorylation-Independent Function in Epithelial Proliferation and Inflammation. Cell Host & Microbe, 5, 23-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Fan, Y., Mao, R. and Yang, J. (2013) NF-κB and STAT3 Signaling Pathways Collaboratively Link Inflammation to Cancer. Protein & Cell, 4, 176-185. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Nagy, T.A., Frey, M.R., Yan, F., et al. (2009) Helicobacter pylori Regulates Cellular Migration and Apoptosis by Activation of Phosphatidylinositol 3-Kinase Signaling. Journal of Infec-tious Diseases, 199, 641-651. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Nakayama, M., Hisatsune, J., Yamasaki, E., et al. (2009) Helicobacter pylori VacA-Induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway. Journal of Biological Chemistry, 284, 1612-1619. [Google Scholar] [CrossRef]
|
|
[60]
|
Lamb, A. and Chen, L.F. (2013) Role of the Helicobacter pylo-ri-Induced Inflammatory Response in the Development of Gastric Cancer. Journal of Cellular Biochemistry, 114, 491-497. [Google Scholar] [CrossRef] [PubMed]
|